 infus stabl prostacyclin analogu iloprost patient peripher vascular diseas lack antiplatelet effect risk thromboembol purpos prostacyclin potent inhibitor platelet function vasodil peripher vascular diseas aim studi thrombot statu patient infus stabl prostacyclin analogu iloprost patient method thirteen patient peripher vascular diseas underw iloprost infus day hour day dose rang ng/kg/minut variabl paramet thrombosi platelet reactiv shear-induc hemostat plug format thrombu format collagen fiber coagul spontan thrombolysi dislodg hemostat plug non-anticoagul blood sampl hemostatometri hour infus last day hour initi infus result analysi data patient hour infus chang platelet reactiv spontan thrombolysi coagul patient signific platelet hyperreact infus patient iloprost infus thrombot reaction enhanc coagul iloprost vitro concentr therapeut peak blood level inhibit platelet function enhanc coagul threshold vitro iloprost concentr anti-platelet effect spontan thrombolysi therapeut blood level conclus find view antagon platelet function import factor iloprost therapi furthermor platelet hyperreact patient enhanc coagul infus iloprost gener risk thromboembol patient prethrombot condit